ro.co glp 1 price Ro Launches Wegovy® Pill Through Integration with Novo Nordisk Ro launches the GLP-1 Insurance
Description
The global GLP-1 nutritional support market size will grow from USD 4.1 billion in 2025 to USD 13 billion by 2035, registering a strong CAGR of 12.2%.
The oral Wegovy pill is now FDA-approved for weight loss
While drug manufacturers sometimes offer discount programs, consumers are often left paying hundreds of dollars out of pocket for their prescriptions
Discover key trends that quick-service restaurants (QSRs) should know about Ozempic/GLP-1 customers, including their preferences, behaviors & more, here.
